Menu Search
Equities

CARETEQ Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CTQ:ASX

CARETEQ Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.009
  • Today's Change0.00 / 0.00%
  • Shares traded500.00k
  • 1 Year change-30.77%
  • Beta0.8440
Data delayed at least 20 minutes, as of Feb 16 2026 05:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Careteq Limited is an Australia-based health-tech company. The Company is focused on medication management solutions. The Company’s brands include Embedded Health Solutions (EHS) and HMR Referrals platforms. The EHS provides comprehensive aged care medication management solutions through Residential Medication Management Reviews (RMMRs), while HMR Referrals streamlines Home Medicines Reviews (HMRs). The Services provided on the HMR Referrals marketplace platform that simplifies and streamlines the HMR processes for general practitioners (GPs) and accredited pharmacists. The HRMs are conducted by a pharmacist with the patient at their home to provide helpful advice on their medications and to optimize their effectiveness.

  • Revenue in AUD (TTM)7.62m
  • Net income in AUD52.75k
  • Incorporated2016
  • Employees--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.